ACT-A External Evaluation
The External Evaluation of the Access To COVID-19 Tools Accelerator (ACT-A) was published on 11 October 2022. The evaluation, commissioned by the ACT-A Facilitation Council, aims to identify lessons learnt that will be of
Key Lessons in ACT-A
The ACT-A Facilitation Council commissioned a global team led by Open Consultants to conduct an external evaluation of ACT-A to identify lessons learnt that will be of use in establishing a better global pandemic preparedness
ACT-A Tracking & Accelerating Progress Working Group hosted a CSO roundtable (September 2022)
On 12 September 2022 the ACT-A Tracking & Accelerating Progress Working Group hosted a CSO roundtable to discuss major gaps in access and delivery of COVID-19 vaccines, diagnostics and therapeutics at the community level, and
Announcement: Interim CSO Representatives to the PPR FIF Governing Board
We are pleased to share Jackline Njeri Kiarie (Amref Health Africa — Global South) and Elisha Dunn-Georgiou (Global Health Council — Global North) have been selected as interim civil society representatives for the new
Response from the Platform for ACT-A Civil Society & Community Representatives to the Berlin declaration (Biopharmaceutical industry vision for equitable access in pandemics)
In response to the Berlin declaration released by the IFPMA (International Federation of Pharmaceutical Manufacturers & Associations) on 19 July, setting out the “Biopharmaceutical industry vision for equitable access in pandemics”, civil society and
Call for Nominations: Global COVID Communities Board
The Platform is currently inviting applications to the Global COVID Communities Board. This process is designed to engage up to a maximum of 20 individuals from communities directly affected by COVID, including living with Long